Sidenav Mini


Money Tuesday September 13th 2022 Morning Stock Newsletter

Goooooood morning Team and Happy MONEY Tuesday!  

Welcome back to ALPHA NATION  I hope everyone had a wonderful evening and that you are all ready to attack this day. I am excited to see what we have in store for today and am ready to lock in some BIG TIME PROFITS with the best trading team in the WORLD!!!

Live Stream is now up and Live Trade Commentary will begin at 9:00AM. We WILL make today an amazing day in the market so get ready team! Let’s GO!



Yesterdays Top Gainers $INM $VTYX $ARQQ $PXMD $ALLG $IDYA


Stock futures rise as Wall Street awaits key inflation report

$GRF Graphex Technologies Enters into MOU with ReCharge Global to Develop Graphite Manufacturing Facilities for Mine-to-Battery Graphite Supply to the EV Industry

$GFAI Guardforce AI Announces LOI to Acquire Shenzhen Kewei Robot Technology Company Limited, a Premier Robotics Technology Company in China

$MDNA Medicenna Announces Clinical Collaboration with Merck to evaluate MDNA11 in combination with KEYTRUDA® (pembrolizumab) in ABILITY Trial

$OTLK Chardan Capital Initiates Coverage On Outlook Therapeutics with Buy Rating, Announces Price Target of $10

$EVGN Canonic Advances its Penetration into Europe by Signing its First Licensing Agreement with GroVida

$FLGC Flora Growth Awarded Best M&A Deal at Benzinga Cannabis Capital Conference

$MRKR Marker Therapeutics Awarded $2 Million Grant from U.S. FDA to Support Marker’s Phase 2 ARTEMIS Trial of MT-401 in Post-Transplant AML

$ASLN ASLAN Pharmaceuticals Announces Acceptance of Two Late-Breaking Abstracts for e-Poster Presentation at the 51st Annual European Society for Dermatological Research Meeting

$AKUS Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss

$LIFE aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod for Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

$AKRO In Akero Therapeutics’ Phase 2b HARMONY Study, Both the 50mg and 28mg EFX Doses Achieved Statistical Significance on Primary and Secondary Histology Endpoints after 24 Weeks

My top stocks for the day

$ETNB is my #1 stock at this time. We broke the 200SMA and are now ripping on up to $6.80. When we look at the daily chart, we can see we have great potential for this stock to run up to $10 then $10.92. Support is back down at $5.63

$AKRO is my #2 stock for today. Fantastic PR and has greta volume here in pre-market. If we break over $26.72 today, I will take this long to $30


Reddit Top Mentions

Market Overview

Largest Short Interest

Economic Calendar


Earnings this Week